Quarterly reports capture key insights on current and future access restrictions within specific oncology therapeutic areas. The data empowers you to maximize your national and regional strategies, turning directional information into tactical insights.
View current payer management behavior for specific brands and overall prioritization of oncology indications.
Create payer profiles on management trends based on unblinded responses.
Observe anticipated coverage changes for the same Commercial and Medicare payer organizations over time.
Understand the power dynamics between payers and IDNs involving oncology treatments.
Improve decision making with a forward-looking analysis into access management topics and therapeutic area management, sourced directly from payers, HCPs, and practice managers representing 75% of Commercial & Medicare lives.
Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.
Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.
P&T Perspectives provides qualitative and tangible feedback through a simulated P&T session that informs your brand’s strategy and helps you determine how your product—or your competitor’s product—will fare in a real P&T Committee review.
Leverage the MMIT Oncology Index to synthesize insights into an analysis of payer trends, oncology management, and disruptive market events.
Our Biologics and Injectables Index helps you access therapeutic area specific data about payer management priorities, IDN dynamics, copay programs, and more.
